Therapy Analysis & Statistics, November 2014

You might be interested in: Therapeutics, Biotherapeutics, Cancer Therapeutics, more »

1-21 of 21 reports

Purchase Reports From Reputable Market Research Publishers

Peptide Therapeutics Database

Peptide Therapeutics Database

  • $ 1 056
  • Industry report
  • November 2014
  • by La Merie Publishing

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on ...

  • Industries : Therapy
Competitor Analysis: Ebola Virus Vaccines and Therapeutics

Competitor Analysis: Ebola Virus Vaccines and Therapeutics

  • $ 264
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the ...

  • Industries : Therapy
Competitor Analysis: Pim Kinase Inhibitors

Competitor Analysis: Pim Kinase Inhibitors

  • $ 132
  • Industry report
  • September 2013
  • by La Merie Publishing

Competitor Analysis: Pim Kinase Inhibitors Product description The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cance ...

  • Industries : Therapy
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

  • $ 330
  • Industry report
  • February 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development ...

  • Industries : Therapy
Competitor Analysis: Pseudomonas aeruginosa Vaccines and Therapeutics

Competitor Analysis: Pseudomonas aeruginosa Vaccines and Therapeutics

  • $ 396
  • Industry report
  • May 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Pseudomonas aeruginosa Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, peptides ...

  • Industries : Therapy
Competitor Analysis: HIV Small Molecule Therapeutics

Competitor Analysis: HIV Small Molecule Therapeutics

  • $ 660
  • Industry report
  • December 2011
  • by La Merie Publishing

Competitior Analysis: HIV Small Molecule Therapeutics The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides ...

  • Industries : Therapy
Competitor Analysis: Novel Mitotic Kinase Inhibitors

Competitor Analysis: Novel Mitotic Kinase Inhibitors

  • $ 528
  • Industry report
  • September 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Novel Mitotic Kinase Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting polo-like kinase 1 (Plk-1), ...

  • Industries : Therapy
Competitor Analysis: Targeted Therapy of Hepatitis C

Competitor Analysis: Targeted Therapy of Hepatitis C

  • $ 792
  • Industry report
  • August 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis ...

  • Industries : Therapy
  • Countries : United States, Japan
RNA Therapeutics Pipeline Database: 1-Year Subscription

RNA Therapeutics Pipeline Database: 1-Year Subscription

  • $ 792
  • Industry report
  • March 2011
  • by La Merie Publishing

Product description Subscription to La Merie's proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include ...

  • Industries : Therapy
Competitor Analysis RNA Therapeutics in Clinical Development

Competitor Analysis RNA Therapeutics in Clinical Development

  • $ 528
  • Industry report
  • March 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about RNA Therapeutics in Clinical Development provides a competitor evaluation in the field of RNA based molecules being developed in clinical ...

  • Industries : Therapy
Therapeutic Protein Pipeline Database: 1-Year Subscription

Therapeutic Protein Pipeline Database: 1-Year Subscription

  • $ 1 584
  • Industry report
  • February 2011
  • by La Merie Publishing

Product description Subscription to La Merie's proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in ...

  • Industries : Therapy
Competitor Analysis FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Competitor Analysis FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

  • $ 330
  • Industry report
  • January 2011
  • by La Merie Publishing

Product description The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of January 2011 provides a competitor analysis in the development ...

  • Industries : Therapy
Competitor Analysis Tau and Amyloid Beta Targeted Therapy of Alzheimer's Disease

Competitor Analysis Tau and Amyloid Beta Targeted Therapy of Alzheimer's Disease

  • $ 924
  • Industry report
  • August 2010
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Tau and Amyloid Beta Targeted Therapy of Alzheimer's Disease provides a competitor evaluation in the field of therapeutic vaccines, ...

  • Industries : Therapy
Competitor Analysis BlyS, BAFF & APRIL

Competitor Analysis BlyS, BAFF & APRIL

  • $ 132
  • Industry report
  • February 2010
  • by La Merie Publishing

Competitor Analysis: BlyS, BAFF & APRIL Product description The present Competitive Intelligence Report about BlyS, BAFF & APRIL Targeted Therapy provides a competitor evaluation in the field of molecules ...

  • Industries : Pathology, Biotechnology, Drug Discovery and Development, Therapy
Competitor Analysis: PSMA & PSA Targeted Therapy

Competitor Analysis: PSMA & PSA Targeted Therapy

  • $ 198
  • Industry report
  • January 2010
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about PSMA & PSA Targeted Therapy provides a competitor evaluation in the field of molecules targeting prostate specific membrane antigen ...

  • Industries : Therapy
Competitor Analysis: Tissue Growth Factors

Competitor Analysis: Tissue Growth Factors

  • $ 1 056
  • Industry report
  • December 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about tissue growth factors provides a competitor evaluation in the field of molecules such as proteins, peptides, antibodies, DNA, RNA, ...

  • Industries : Therapy, Pharmaceutical
Competitor Analysis: Proteasome Inhibitors

Competitor Analysis: Proteasome Inhibitors

  • $ 132
  • Industry report
  • November 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Proteasome Inhibitors provides a competitor evaluation in the field of novel small molecules and peptides targeting the proteasome ...

  • Industries : Research and Development, Therapy
Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists

Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists

  • $ 792
  • Industry report
  • September 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules ...

  • Industries : Therapy, Biotechnology, Pharmaceutical
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors

Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors

  • $ 264
  • Industry report
  • July 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Bcr-Abl and Src Kinase Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting Bcr-Abl ...

  • Industries : Therapy, Biotechnology, Pharmaceutical
  • Countries : United States
Competitor Analysis: Aurora Kinase Inhibitors

Competitor Analysis: Aurora Kinase Inhibitors

  • $ 231
  • Industry report
  • June 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Aurora Kinase Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting aurora kinase for treatment ...

  • Industries : Therapy, Biotechnology, Pharmaceutical
Competitor Analysis: PARP Inhibitors

Competitor Analysis: PARP Inhibitors

  • $ 132
  • Industry report
  • April 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about PARP Inhibitors provides a competitor evaluation in the field of investigational small molecules inhibiting poly-adenyl-ribose ...

  • Industries : Therapy, Biopharmaceutical


About 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Industry - Company Report, November 2014

  • Boston Therapeutics Reports third Quarter Results and Provides C...
  • November 2014
    6 pages
  • Therapeutics  

  • United States  

    North America  

View report >

Therapy Markets In The Us

September 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.